Stifel Financial’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$415K Buy
134,616
+11,200
+9% +$47.6K ﹤0.01% 2970
2025
Q4
$446K Buy
123,416
+63,005
+104% +$275K ﹤0.01% 2929
2025
Q3
$228K Buy
60,411
+18,851
+45% +$72.8K ﹤0.01% 3271
2025
Q2
$161K Buy
41,560
+5,060
+14% +$27.4K ﹤0.01% 3299
2025
Q1
$183K Buy
36,500
+23,397
+179% +$148K ﹤0.01% 3207
2024
Q4
$94.5K Sell
13,103
-4,649
-26% -$35.5K ﹤0.01% 3250
2024
Q3
$109K Buy
17,752
+7,746
+77% +$52.5K ﹤0.01% 3230
2024
Q2
$66.5K Buy
+10,006
New +$73.8K ﹤0.01% 3253

Other funds holding ALT

Stifel Financial's ALT Position: Q1 2026 in Review

Stifel Financial increased its Altimmune (ALT) stake by 9.1% in Q1 2026, buying an estimated $47.6K and bringing the position to 134,616 shares worth $415K. The position accounts for ﹤0.01% of the portfolio, ranked #2970.

Stifel Financial first reported a position in ALT in Q2 2024 and has held it in 8 quarters since. The position peaked at $446K in Q4 2025. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Stifel Financial held 134,616 shares of Altimmune worth $415K as of Q1 2026.
  • Stifel Financial bought 11,200 Altimmune shares in Q1 2026, an estimated $47.6K.
  • Altimmune made up ﹤0.01% of Stifel Financial's portfolio in Q1 2026, its #2970 holding.
  • Stifel Financial first reported a position in Altimmune in Q2 2024 and has held it in 8 quarters since.
  • Stifel Financial's Altimmune position peaked at $446K in Q4 2025.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.